Warrant
Shares Underlying
Exercise Price
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 26 of Context Therapeutics Inc.'s SEC filings and found 4 warrant series, 1 ATM program and 3 shelf registrations on file for CNTX. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 4, 2026.
CNTX
Pre-revenue biotech burning cash
Context Therapeutics is a clinical-stage biotech focused on cancer treatments that currently generates no revenue and burns through cash to fund research.
Raise routes on file: active ATM + effective shelf · latest dilution event 126 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Jun 30, 2026 · ATM Sale
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Issued 2024
Shares Underlying
Exercise Price
Issued 2024
Total capacity
Sold to date
Issued 2024
Total capacity
Remaining
Issued 2022
Total capacity
Remaining
Issued 2024
Total capacity
Remaining
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z